{"id":111568,"date":"2025-11-21T04:58:42","date_gmt":"2025-11-21T04:58:42","guid":{"rendered":"https:\/\/insights.greyb.com\/?post_type=ht_kb&p=111568"},"modified":"2025-11-21T04:58:45","modified_gmt":"2025-11-21T04:58:45","slug":"kronos-bio-patents","status":"publish","type":"ht_kb","link":"https:\/\/insights.greyb.com\/kronos-bio-patents\/","title":{"rendered":"Kronos Bio Patents – Insights & Stats (Updated 2025)"},"content":{"rendered":"\n

Kronos Bio has a total of 196 patents globally, out of which 119 have been granted. Of these 196 patents, 67% patents are active. The United States of America is where Kronos Bio has filed the maximum number of patents, followed by Australia and Canada. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Kronos Bio.<\/p>\n\n\n\n

Kronos Bio was founded in 2017. The company is a clinical-stage biopharmaceutical developer focused on creating innovative cancer therapies. It specializes in discovering and advancing small-molecule drugs that target deregulated transcription an underlying driver of many cancers and autoimmune disorders.<\/p>\n\n\n\n

Do read about some of the most popular patents of Kronos Bio which have been covered by us in this article and also you can find Kronos Bio patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Kronos Bio patent portfolio.<\/p>\n\n\n\n

How many patents does <\/strong>Kronos Bio <\/strong>have?<\/strong><\/h3>\n\n\n\n

Kronos Bio has a total of 196 patents globally. These patents belong to 34 unique patent families. Out of 196 patents, 133 patents are active.<\/p>\n\n\n\n

How Many Patents did Kronos Bio File Every Year?<\/strong><\/h3>\n\n\n\n
\"Kronos<\/a><\/figure>\n\n\n\n

Are you wondering why there is a drop in patent filing for the last two years? <\/strong>It is because a patent application can take up to 18 months to get published. Certainly, it doesn\u2019t suggest a decrease in the patent filing.<\/p>\n\n\n\n

Year of Patents Filing or Grant<\/strong><\/td>Kronos Bio Applications Filed<\/strong><\/td>Kronos Bio Patents Granted<\/strong><\/td><\/tr>
2025<\/td>2<\/td>5<\/td><\/tr>
2024<\/td>7<\/td>8<\/td><\/tr>
2023<\/td>4<\/td>6<\/td><\/tr>
2022<\/td>12<\/td>7<\/td><\/tr>
2021<\/td>17<\/td>19<\/td><\/tr>
2020<\/td>10<\/td>17<\/td><\/tr>
2019<\/td>20<\/td>7<\/td><\/tr>
2018<\/td>9<\/td>16<\/td><\/tr>
2017<\/td>12<\/td>11<\/td><\/tr>
2016<\/td>13<\/td>9<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

How many <\/strong>Kronos Bio <\/strong>patents are Alive\/Dead?<\/strong><\/h3>\n\n\n\n

Worldwide Patents<\/strong><\/p>\n\n\n\n

\"Kronos<\/a><\/figure>\n\n\n\n

How Many Patents did Kronos Bio File in Different Countries?<\/strong><\/h3>\n\n\n\n
\"Kronos<\/a><\/figure>\n\n\n\n

Countries in which Kronos Bio Filed Patents<\/strong><\/h3>\n\n\n\n
Country<\/strong><\/td>Patents<\/strong><\/td><\/tr>
United States of America<\/td>58<\/td><\/tr>
Australia<\/td>13<\/td><\/tr>
Canada<\/td>10<\/td><\/tr>
Europe (EPO)<\/td>9<\/td><\/tr>
Hong Kong (S.A.R.)<\/td>8<\/td><\/tr>
Taiwan<\/td>5<\/td><\/tr>
New Zealand<\/td>5<\/td><\/tr>
Norway<\/td>5<\/td><\/tr>
Austria<\/td>5<\/td><\/tr>
Africa<\/td>4<\/td><\/tr>
South Africa<\/td>4<\/td><\/tr>
Portugal<\/td>3<\/td><\/tr>
Germany<\/td>3<\/td><\/tr>
Italy<\/td>3<\/td><\/tr>
Denmark<\/td>3<\/td><\/tr>
Indonesia<\/td>3<\/td><\/tr>
Brazil<\/td>3<\/td><\/tr>
Korea (South)<\/td>3<\/td><\/tr>
Mexico<\/td>3<\/td><\/tr>
Spain<\/td>3<\/td><\/tr>
Hungary<\/td>2<\/td><\/tr>
Slovakia<\/td>2<\/td><\/tr>
Chile<\/td>2<\/td><\/tr>
Slovenia<\/td>2<\/td><\/tr>
Croatia<\/td>2<\/td><\/tr>
China<\/td>2<\/td><\/tr>
Singapore<\/td>2<\/td><\/tr>
Kenya<\/td>2<\/td><\/tr>
Philippines<\/td>2<\/td><\/tr>
Poland<\/td>2<\/td><\/tr>
Saudi Arabia<\/td>1<\/td><\/tr>
Israel<\/td>1<\/td><\/tr>
Viet Nam<\/td>1<\/td><\/tr>
Malaysia<\/td>1<\/td><\/tr>
Panama<\/td>1<\/td><\/tr>
Costa Rica<\/td>1<\/td><\/tr>
Russia<\/td>1<\/td><\/tr>
Eurasia<\/td>1<\/td><\/tr>
India<\/td>1<\/td><\/tr>
Colombia<\/td>1<\/td><\/tr>
Peru<\/td>1<\/td><\/tr>
Dominican Republic<\/td>1<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

Where are Research Centers of Kronos Bio Patents\u00a0Located?<\/strong><\/h3>\n\n\n\n
\"R&D<\/a><\/figure>\n\n\n\n

10 Best <\/strong>Kronos Bio <\/strong>Patents<\/strong><\/strong><\/h3>\n\n\n\n

US8450321B2<\/a> is the most popular patent in the Kronos Bio portfolio. It has received 376 citations so far from companies like Gilead Sciences, I-Mab, Phosphorex.<\/p>\n\n\n\n

Below is the list of 10 most cited patents of Kronos Bio:<\/strong><\/h3>\n\n\n\n
Publication Number<\/strong><\/td>Citation Count<\/strong><\/td><\/tr>
US8450321B2<\/a><\/td>376<\/td><\/tr>
US8455493B2<\/a><\/td>102<\/td><\/tr>
US8440667B2<\/a><\/td>65<\/td><\/tr>
US20180071303A1<\/a><\/td>49<\/td><\/tr>
US8748607B2<\/a><\/td>37<\/td><\/tr>
US20140148430A1<\/a><\/td>37<\/td><\/tr>
US20130267496A1<\/a><\/td>37<\/td><\/tr>
US20160220573A1<\/a><\/td>35<\/td><\/tr>
US20090221612A1<\/a><\/td>34<\/td><\/tr>
US8765761B2<\/a><\/td>30<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

What Percentage of Kronos Bio US Patent Applications were Granted?<\/strong><\/h3>\n\n\n\n

Kronos Bio (Excluding its subsidiaries) has filed 57 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 40 have been granted leading to a grant rate of 76.92%<\/strong>.<\/p>\n\n\n\n

Below are the key stats of Kronos Bio patent prosecution at the USPTO.<\/p>\n\n\n\n

\"\"<\/a><\/figure>\n\n\n\n

Which Law Firms are managing US Patents for Kronos Bio?<\/strong><\/h3>\n\n\n\n
Law Firm<\/strong><\/td>Total Applications<\/strong><\/td>Success Rate<\/strong><\/td><\/tr>
Knobbe Martens Olson & Bear Llp<\/td>35<\/td>100.00%<\/td><\/tr>
Gilead Sciences Inc<\/td>18<\/td>38.89%<\/td><\/tr>
Epa Bozicevic Field & Francis Llp<\/td>3<\/td>100.00%<\/td><\/tr>
Morrison & Foerster Llp<\/td>1<\/td>0.00%<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

What are Kronos Bio key innovation segments?<\/strong><\/h3>\n\n\n\n\n